Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics

Similar documents
Original Article Etiologic and clinical analysis of chronic complex anal and rectal inflammation in children less than 3 years old

Original Article. Distinguishing Crohn s disease from intestinal tuberculosis a prospective study

What do we need for diagnosis of IBD

Mohamed EL-hemaly Gastro- intestinal surgical center, Mansoura University.

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn s disease from tuberculosis

Visceral Fat as a Useful Parameter in the Differential Diagnosis of Crohn s Disease and Intestinal Tuberculosis

Research Article Comparison between Intestinal Behçet s Disease and Crohn s Disease in Characteristics of Symptom, Endoscopy, and Radiology

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Endoscopic Diagnosis and Differentiation of Inflammatory Bowel Disease

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

The aim of this study was to find the diagnostic yield of ileoscopy in patients undergoing colonoscopy.

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

Treating Crohn s and Colitis in the ASC

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

Guided by Dr. Michal Amitai Head of Abdominal Imaging Department of Diagnostic Imaging Sheba Medical Center Sackler School of Medicine, Tel Aviv

Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn s disease

CROHN S DISEASE. The term "inflammatory bowel disease" includes Crohn's disease and the other related condition called ulcerative colitis.

Crohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation?

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

Crohn s Disease. Resident Lecture 1/17/19

Endoscopy in IBD. F.Hartmann K.Kasper-Kliniken (St.Marienkrankenhaus) Frankfurt/M.

Corporate Medical Policy

The Spectrum of IBD. Inflammatory Bowel Disease. Symptoms. Epidemiology. Tests for IBD. CD or UC? Inflamatory Bowel Disease. Fernando Vega, M.D.

INFLAMMATORY BOWEL DISEASE

The Challenge of Inflammatory Bowel Disease Diagnosis in Asia

Tissue Polymerase Chain Reaction in Diagnosis of Intestinal Tuberculosis and Crohn s Disease

What is the most accurate method for the diagnosis of intestinal tuberculosis?

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

A Case of Crohn s Disease with Mesalazine Allergy that was Difficult to Differentiate from Comorbid Ulcerative Colitis

Indian Society of Gastroenterology consensus statements on Crohn s disease in India

Jonathan R. Dillman, MD, MSc. Associate Professor Department of Radiology Cincinnati Children s Hospital Medical Center

Tubercular versus Crohn s ileal strictures: role of endoscopic balloon dilatation without fluoroscopy

STATEMENT INTRODUCTION EPIDEMIOLOGY

Deep Enteroscopy Methods to Diagnose Small Bowel IBD

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

Original Research Article

Intestinal tuberculosis and tuberculous peritonitis

Filiform polyposis of ulcerative colitis

Faecal Calprotectin. Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS)

Quality Measures In Colonoscopy: Why Should I Care?

How to differentiate Segmental Colitis Associated with Diverticulosis and Inflammatory Bowel Diseases?

Clinical Management of Obscure- Overt Gastrointestinal Bleeding. Presented by Dr. 張瀚文

The Role of Ultrasound in the Assessment of Inflammatory Bowel Disease

Clinico-pathological study of colonoscopic biopsies in patients with chronic diarrhea

Epidemiology and Treatment of Colonic Angiodysplasia; a Population-Based Study. Naomi G. Diggs, MD Lisa L. Strate, MD MPH March 2, 2010

Histomorphological Spectrum of Gastrointestinal Tuberculosis

Mucosal healing: does it really matter?

EDITOR S PICK RECENT ADVANCES IN THE DIAGNOSIS AND MANAGEMENT OF ABDOMINAL TUBERCULOSIS

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

Implementation of disease and safety predictors during disease management in UC

Ali Keshavarzian MD Rush University Medical Center

CRC and Dysplasia in IBD: Objectives of Talk. Colorectal Cancer and Dysplasia in IBD: A Case-Based Approach. Page 1

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium

For the past 40 years, it has been standard practice to obtain

A Case of Gastric Tuberculosis Mimicking Advanced Gastric Cancer

An Unusual Complication of Crohn s Disease. Dr Gerald Busuttil Mr Debono s Firm Surgical Grand Round 25 th November 2008

Crohn's Disease. The What, When, and Why of Treatment

Colonoscopic study of 50 patients with colonic tuberculosis

My Child Has Inflammatory Bowel Disease : Why? What now? What s next?

Chromoendoscopy - Should It Be Standard of Care in IBD?

Research Article Small Bowel Endoscopy Diagnostic Yield and Reasons of Obscure GI Bleeding in Chinese Patients

ד"ר דוד ירדני המכון לגסטרואנטרולוגיה ומחלות כבד מרכז רפואי סורוקה

Fibrotic complications of inflammatory bowel disease

GRANULOMATOUS COLITIS: SIGNIFICANCE OF INVOLVEMENT OF THE TERMINAL ILEUM

Endoscopic Corner CASE 1. Kimtrakool S Aniwan S Linlawan S Muangpaisarn P Sallapant S Rerknimitr R

Crohn s Disease: A New Approach to an Old Problem

Impact of endoscopic monitoring in postoperative Crohn s disease patients already receiving pharmacological prevention of recurrence

children Crohn s disease in MR enterography for GI Complications Microscopy Characterization Primary sclerosing cholangitis Anorectal fistulae

Diagnosis and Treatment of Hematoschezia: Guideline for Clinical Practice

Small bowel carcinoma mimicking a relapse of Crohn's disease: A case series

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)

The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs.

Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R.

Tuberculosis and Crohn's Disease Revisited

Grand round on a case of ileocecal tuberculosis. Presenters Alula (R3) Getahun (R1) Berhanu (Intern) Department of internal medicine April 2014

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis

Case Report Filiform Polyposis Secondary to Colonic Tuberculosis Presenting as Acute Colo-Colonic Intussusception

PEDIATRIC INFLAMMATORY BOWEL DISEASE

Ulcerative Colitis. ulcerative colitis usually only affects the colon.

Extracorporeal Photopheresis and Crohn s Disease. Jill Adamski MD, PhD Transfusion Medicine Department of Pathology

Unexpected Findings at Endoscopy

World Journal of Colorectal Surgery

... Inflammatory disorder of the colon that occurs as a complication of antibiotic treatment.

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

Case Report Hematochezia: An Uncommon Presentation of Colonic Tuberculosis

Diseases of the Colon. Jack Bragg, D.O., F.A.C.O.I.

History of IBD in India

Emergence of Celiac Disease and Crohn s Disease in India

ACG Clinical Guideline: Management of Crohn s Disease in Adults

The value of colonoscopy in isolated abdominal pain. Dr Aaditya Narendra, Dr Yi Ling Adeline Lim, Dr Casper Francois Pretorius

Crohn's Disease. What causes Crohn s disease? What are the symptoms?

This information explains the advice about Crohn's disease that is set out in NICE guideline CG152.

Transcription:

38 Original Article Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics Anuchapreeda S Leelakusolvong S Charatcharoenwitthaya P Nimanong S Chainuvati S Manatsathit S Pongprasobchai S Pausawasdi N Prachayakul V Chotiyaputta W Tanwandee T Kachintorn U ABSTRACT Background: Differentiation between ileocolonic tuberculosis () and Crohn s disease () is difficult but very important. Data on this issue is scarce and inconsistent. Methods: Clinical, endoscopic and biopsy results of 27 patients and 33 patients were analyzed and compared. Results: The only useful clinical feature to distinguish from was host immune status (odds ratio 51 for, p <0.001). The presence of immunocompetency was associated with sensitivity, specificity, PPV and NPV of 100%, 39%, 68% and 0%, respectively for the diagnosis of. The only endoscopic feature that helped distinguishing from was the number of ulcers of 4 or more (odds ratio 4.67 for, 95% CI 1.12-19.54, p = 0.004), with sensitivity, specificity, PPV and NPV of 84%, 47%, 70% and 33%, respectively for. A single biopsy session, together with searching for evidence of extraintestinal led to the diagnosis of in all patients, whereas in, even multiple colonoscopies and biopsy sessions could definitely diagnose in only 11.8%. Conclusion: Patient immune status, number of ulcers and result of single biopsy session could distinguish ileocolonic from in most patients. Key words : clinical, Crohn s disease, differentiate, distinguish, endoscopy, histology, tuberculosis [Thai J Gastroenterol ; 13(1): 38-42.] INTRODUCTION Intestinal tuberculosis () and Crohn s disease () are chronic granulomatous diseases of the intestine. Both diseases usually involve the terminal ileum and the colon, causing difficulty in clinical practice to differentiate the two conditions. Although histologic findings from endoscopic biopsy can definitely diagnose intestinal by identifying acid-fast bacilli or positive culture, it is not so sensitive. On the other hand, histology is usually not specific enough to diagnose, thus diagnosis is usually based on clinical grounds and after excluding other diseases, including. Since the treatment and prognosis of both diseases are quite different, misdiagnosis leading to treat- Division of Gastroenterology, Department of Internal Medicine, Siriraj Hospital, Bangkok. Address for Correspondence: Supot Pongprasobchai, M.D., Division of Gastroenterology, Department of Internal Medicine, Siriraj Hospital, Bangkok.

Anuchapreeda S, et al. Vol. 13 No. 1 Jan. - Apr. 39 Performance of tissue diagnosis Diagnosis of ileocolonic was achieved in all patients with only one session of colonoscopy. Histoing as or vice versa will delay proper treatment and can be harmful. In clinical practice therefore, differentiation between the two conditions is critical. Thus far, there have been only few studies trying to determine clinical, endoscopic or histologic features to differentiate between the two diseases (1-6). The results were either inconsistent or impractical to use. The purpose of this study is to identify clinical, endoscopic and histologic characteristics that may help differentiating between ileocolonic and. MATERIAL AND METHOD Data records of all patients diagnosed as ileocolonic and at Siriraj Hospital, Bangkok, from January 2005 to January 2011 were retrieved and were retrospectively reviewed and analyzed. Diagnosis of and Ileocolonic was diagnosed by any of the followings: histologic finding of caseating granuloma microscopic finding of acid-fast bacilli positive culture for Mycobacterium tuberculosis, positive polymerase chain reaction (PCR) for Mycobacterium tuberculosis, or concurrent active in other organ(s) with response to antituberculous therapy. Ileocolonic was diagnosed by the presence of two of the followings: stricture or fistula on radiographic study, macroscopic appearance of induration in the bowel wall, mesenteric lymphadenopathy creeping fat at laparotomy, inflammation of the bowel wall on microscopic appearance, and response to immunosuppressive drugs (i.e. corticosteroids, azathioprine, or sulfasalazine/5-aminosalicylates) Data collection Clinical and histopathological data were collected from chart reviews. Endoscopic data were collected from both endoscopic reports and all photos were rereviewed by two of the authors (S.A. and S.P.). Discordances were solved by the third author (S.L.), or by consensus. Statistical analysis Statistical evaluation was performed using SPSS software (Version 17). Continuous variables, e.g. age and size of lesions, were presented in mean, median, standard variation and range. Categorical data and proportions were compared by using Pearson s chi-squared test, or Fisher s exact test as appropriate. A of less than 0.05 was considered to be significant. Sensitivity and specificity of the identified features were calculated. This study was approved by Siriraj Institutional Review Board. RESULTS One-hundred-thirty-four patients with ileocolonic lesions were initially identified. After long-term follow-up, 27 patients had definite ileocolonic and 33 patients had. Clinical data were complete in all patients. For colonoscopic findings, 9 and 7 patients were excluded because of incomplete colonoscopic results, either due to failure to reach the caecum or to enter the terminal ileum. Thus, colonoscopic data of 18 ileocolonic and 27 ileocolonic were finally obtained. Clinical features Comparison of demographics data, symptoms and signs between patients with ileocolonic and is shown in Table 1. The only clinical data that was significantly different between the two diseases was the underlying diseases. was universally found in normal hosts, while all immunocompromised patients had (p = 0.001). History of oral aphthous ulcers was more common in than in (27.2% vs. 3.8%, respectively, p = 0.053). Other demographic and clinical features were not significantly different between and. Endoscopic features Details of the colonoscopic features of and are compared in Table 2. Sites of involvement were not different. Ulcer sizes were similar, however were more commonly multiple with 4 ulcers than (84% vs. 53%, p = 0.029). Ulcer shapes were also similar, since both and ulcers are mostly transverse (77.8% and 84.6%, p = 0.432). Patulous ileocaecal valve favored than, whereas pseudopolyps, cobblestone appearance, scar and stricture were more commonly found in than in, but without statistical significance.

40 Table 1. Comparison of demographic data, symptoms and signs between patients with ileocolonic and. (n = 27) (n = 33) Male gender, n (%) 16 (59.3) 19 (57.6) 0.895 Age (years), mean ± SD 45.1 ± 16.7 44.2 ± 21.6 0.544 Underlying diseases, n (%) Normal 15 (62.5) 33 (100) 0.001 HIV 6 (25) 0 Others 3 (12.5) 0 Fever, n (%) 10 (38.5) 11 (33.3) 0.683 Abdominal pain, n (%) 19 (73.1) 24 (72.7) 0.976 Abdominal mass, n (%) 3 (11.5) 2 (6.1) 0.453 Diarrhea, n (%) 12 (54.5) 21 (80.8) 0.051 Lower GI bleeding, n (%) 4 (15.4) 12 (36.4) 0.072 Weight loss, n (%) 19 (79.2) 26 (81.3) 0.846 Aphthous ulcer, n (%) 1 (3.8) 7 (27.2) 0.053 Perianal lesions, n (%) 4 (15.4) 6 (18.2) 0.776 Arthritis, n (%) 0 1 (3.0) 0.371 Uveitis, n (%) 0 1 (3.0) 0.371 Table 2. Comparison of colonoscopic features between ileocolonic and. (n = 18) (n = 26) Location, n (%) Terminal ileum alone 2 (11.1) 8 (30.8) 0.161 Colon alone 7 (38.9) 9 (34.6) 0.772 Terminal ileum + caecum 1 (5.6) 2 (7.7) 0.782 Terminal ileum + colon 9 (50) 9 (34.6) 0.307 Ulcer shape, n (%) Transverse 14 (77.8) 22 (84.6) 0.432 Longitudinal 0 1 (3.8) Combined 1 (5.6) 2 (7.7) Unclassified* 3 (16.7) 1 (3.8) Ulcer characters, n (%) Aphthoid 6 (33.3) 8 (30.8) 0.858 Flat ulcer 14 (77.8) 22 (84.6) 0.697 Ulcerative mass 3 (16.7) 3 (11.5) 0.676 Number and size of ulcers Number 4, n (%) 9 (52.9) 21 (84.0) 0.029 Size (cm), mean ± SD 2.0 ± 1.6 2.6 ± 1.4 0.209 Others, n (%) Patulous ileocaecal valve 4 (28.6) 3 (11.5) 0.422 Pseudopolyps 3 (16.7) 9 (34.6) 0.303 Cobberstone appearance 3 (16.7) 6 (23.1) 0.716 Nodularity 5 (21.8) 3 (11.5) 0.240 Scar 0 6 (23.1) 0.067 Stricture 1 (5.6) 3 (11.5) 0.634 *Aphthoid or small round ulcers

Anuchapreeda S, et al. Vol. 13 No. 1 Jan. - Apr. 41 Table 3. Comparison of the number of colonoscopy needed and the performance of tissue biopsy to diagnose ileocolonic or. (n = 18) (n = 26) Number of colonoscopy 1 18 (100) 14 (53.8) <0.001 2 0 6 (23.1) 3 0 3 (11.5) 4 0 3 (11.5) Pathological diagnosis Definite 15 (83.3) 3 (11.5) <0.001 Not definite 3 (16.7)* 23 (88.4) *Diagnoses were made by the presence of extraintestinal Table 4. Diagnostic performance of the two distinguishable features between and. OR Sensitivity Specificity PPV NPV 95% CI (for ) (%) (%) (%) (%) Immunocompetence 51 NA* < 0.001 100 39 68 0 Number of ulcer 4 4.67 1.12-19.54 0.041 84 47 70 33 *NA: not assessable Table 5. Prediction of the likelihood of ileocolonic or based on the presence or absence of the two distinguishable features. Host Ulcer number n Immucompetent 4 24 21 (87.5) 3 (12.5) Immucompetent < 4 8 4 (50) 4 (50) Immunocompromised 4 5 0 (0) 5 (100) Immunocompromised < 4 4 0 (0) 4 (100) pathology could promptly diagnose in 83.3% of the cases. In the remaining cases (16.7%) with nondiagnostic biopsy, the diagnosis of was made from the presence of concomitant extraintestinal (1 patient), positive culture (1 patient), and response to antituberculous medications (1 patient). The sensitivities of AFB stain, culture and PCR for diagnosing were 76.5%, 44.4%, and 14.3% respectively. In contrast, 46.2% of patients needed more than one session of colonoscopy, and even then, definitive diagnosis was achieved in only 11.5% (Table 3). Diagnostic performance of the distinguishable features Diagnostic performances of the 2 distinguishable features between and, namely the host immune status and the number of ulcers 4, are shown in Table 4. Prediction of the likelihood of or based on the presence or absence of these two features is shown in Table 5. DISCUSSION In the present study, we could identify 2 parameters, 1 clinical and 1 endoscopic, that could help distinguishing between ileocolonic and, namely the host immune status and the number of ulcers. Crohn s disease always occurred in immunocompetent patients the number of ulcers was usually 4, whereas could affect both the immunocompromised and the immunocompetent patients and the number of ulcers were often < 4. Other clinical and endoscopic features

42 were not helpful, in keeping with the diagnostic difficulty in those two diseases. Additionally, the present study indicated that the combination of single tissue biopsy session and evidence of extracolonic was very sensitive for diagnosing of, making repeating colonoscopic biopsy unnecessary. Crohn s disease, on the other hand, could not usually be diagnosed by histology, even with multiple repetitions. Repeating colonoscopy and biopsy are rarely helpful in. The results of the present study differ from previous reports. Regarding clinical features, our study fails to confirm that hematochezia (2), weight loss (2), fever (2), diarrhea (2), perianal lesions (1,5), pulmonary (5) or ascites (5) are useful for distinguishing from. Previous surgery has been shown useful in favor of in one study (5), but not in our study with very few operative cases. Positive fecal occult blood was shown to favor, while positive PPD skin test was for (the latter two tests are not commonly used in Thailand, however, and so not in our study). The reasons why our results differ from others are not obvious, but may be from the small number of our cases. We found host immune status very helpful for distinguishing from, immunocompromised always. This finding has not been reported previously. Our study did not indicate that endoscopic characteristics, particularly ulcer alignment (transverse or longitudinal) were helpful. Some studies previously suggested that transverse ulcers favored while longitudinal ulcers favored. In our study, we noted that both and ulcers usually were transverse, and longitudinal ulcers were uncommon and would when present indicate. We also found that to describe ulcer shape as transverse or longitudinal was not easy, as most cases had both, and no standard definition exists on how to classify ulcer shape. Thus, we assumed that transverse ulcers mean number of transverse was more than 2/3 of all ulcers (and similarly for longitudinal ulcers) and combined ulcers were called when the numbers of each ulcer type were between 1/ 3 to 2/3. A patulous IC valve was also not helpful in our study. Instead, we found that number of ulcers, which was more easily determined, helped distinguish from (more ulcers, more likely to be ). This finding has not been mentioned in any previous study. An important finding in our study was that single biopsy session was sufficient to diagnose, whereas repeating biopsy was not enough for. Repeating colonoscopy and biopsy, therefore, may not be necessary for either or. This finding together with the above mentioned clinical and endoscopic features may enable an earlier diagnosis and treatment as well as avoiding repeat investigations. There were some limitations in the present study. Firstly, the retrospective nature of the study inevitably resulted in some incomplete data record. However, due to very low prevalence of the diseases in Thailand particularly (7), a prospective study design would be very difficult. Secondly, the number of patients in each group was rather small. Thus, many potentially distinguishable features were short of statistical significance. The completeness of colonoscopic description of lesions was another problem. Therefore only patients endoscoped after 2005 were chosen as captured colonoscopic photos had since been systematically recorded and available for review. In conclusion, patient immune status, number of ulcers by colonoscopy and result of the first biopsy can help distinguish between ileocolonic and. Conflict of interest None REFERENCES 1. Lee YJ, Yang SK, Byeon JS, et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn s disease. Endoscopy 2006;38:592-7. 2. Amarapurkar DN, Patel ND, Rane PS. Diagnosis of Crohn s disease in India where tuberculosis is widely prevalent. World J Gastroenterol 2008;14:741-6. 3. Zhou ZY, Luo HS. Differential diagnosis between Crohn s disease and intestinal tuberculosis in China. Int J Clin Pract 2006;60:212-4. 4. Makharia GK, Srivastava S, Das P, et al. Clinical, endoscopic, and histological differentiations between Crohn s disease and intestinal tuberculosis. Am J Gastroenterol 2010;105:642-51. 5. Li X, Liu X, Zou Y, et al. Predictors of clinical and endoscopic findings in differentiating Crohn s disease from intestinal tuberculosis. Dig Dis Sci 2011;56:188-96. 6. Pulimood AB, Ramakrishna BS, Kurian G, et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn s disease from tuberculosis. Gut 1999;45:537-41. 7. Rerknimitr R, Chalapipat O, Kongkam P, et al. Clinical characteristics of inflammatory bowel disease in Thailand: a 16 years review. J Med Assoc Thai 2005;88 (Suppl 4):S129-33.